Connection

Andrew Kraft to Prostate-Specific Antigen

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Prostate-Specific Antigen.
Andrew Kraft
Connection Strength
0.111
Prostate-Specific Antigen
  1. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther. 2011 Jul 15; 12(2):119-24.
    View in: PubMed
    Score: 0.086
  2. A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy. Anticancer Drugs. 2013 Aug; 24(7):743-53.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.